The 4000th eye tumour patient treated with protons at HZB
Overview: Number of patients treated with prontons at HZB from 1998 to 2020. © HZB/S. Kodalle
On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.
For more than 20 years, Charité - Universitätsmedizin Berlin and Helmholtz-Zentrum Berlin (HZB) have jointly offered irradiation of eye tumours with protons. For this purpose, the HZB operates a proton accelerator, while the medical care of patients is provided by the Charité.
"We congratulate the joint team on this great success and thank them for doing everything they could under the difficult pandemic conditions to maintain the operation of the life-saving eye tumour therapy," says Prof. Bernd Rech, spokesman for the scientific management of HZB.
500 to 600 people contract malignant uveal melanoma in Germany every year. In 97 percent of cases, the tumour can be completely destroyed by irradiation with protons. In most cases, not only the eye but also the vision can be preserved to a satisfactory degree. Radiation with protons is a particularly effective method: the energy of the proton beam can be adjusted in such a way that practically only the tumour receives the radiation, while the surrounding healthy tissue is spared.
- Green hydrogen: A cage structured material transforms into a performant catalystClathrates are characterised by a complex cage structure that provides space for guest ions too. Now, for the first time, a team has investigated the suitability of clathrates as catalysts for electrolytic hydrogen production with impressive results: the clathrate sample was even more efficient and robust than currently used nickel-based catalysts. They also found a reason for this enhanced performance. Measurements at BESSY II showed that the clathrates undergo structural changes during the catalytic reaction: the three-dimensional cage structure decays into ultra-thin nanosheets that allow maximum contact with active catalytic centres. The study has been published in the journal ‘Angewandte Chemie’.
- Solar cells on moon glass for a future base on the moonFuture settlements on the moon will need energy, which could be supplied by photovoltaics. However, launching material into space is expensive – transporting one kilogram to the moon costs one million euros. But there are also resources on the moon that can be used. A research team led by Dr. Felix Lang of the University of Potsdam and Dr. Stefan Linke of the Technical University of Berlin have now produced the required glass from ‘moon dust’ (regolith) and coated it with perovskite. This could save up to 99 percent of the weight needed to produce PV modules on the moon. The team tested the radiation tolerance of the solar cells at the proton accelerator of the HZB.
- Optical innovations for solar modules - which are the most promising?In 2023, photovoltaic systems generated more than 5% of the world’s electrical energy and the installed capacity doubles every two to three years. Optical technologies can further increase the efficiency of solar modules and open up new applications, such as coloured solar modules for facades. Now, 27 experts provide a comprehensive overview of the state of research and assess the most promising innovations. The report, which is also of interest to stakeholders in funding and science management, was coordinated by HZB scientists Prof. Christiane Becker and Dr. Klaus Jäger.